These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10884474)

  • 1. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia.
    Phillips JB; Williams AJ; Adams J; Elliott PJ; Tortella FC
    Stroke; 2000 Jul; 31(7):1686-93. PubMed ID: 10884474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.
    Williams AJ; Hale SL; Moffett JR; Dave JR; Elliott PJ; Adams J; Tortella FC
    J Cereb Blood Flow Metab; 2003 Jan; 23(1):75-87. PubMed ID: 12500093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
    Williams AJ; Berti R; Dave JR; Elliot PJ; Adams J; Tortella FC
    Stroke; 2004 May; 35(5):1186-91. PubMed ID: 15060320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
    Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
    Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
    Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia.
    Nito C; Ueda M; Inaba T; Katsura K; Katayama Y
    Neurol Res; 2011 Oct; 33(8):881-9. PubMed ID: 22004713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
    Mokudai T; Ayoub IA; Sakakibara Y; Lee EJ; Ogilvy CS; Maynard KI
    Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
    Goyagi T; Toung TJ; Kirsch JR; Traystman RJ; Koehler RC; Hurn PD; Bhardwaj A
    Stroke; 2003 Jun; 34(6):1533-8. PubMed ID: 12738895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat.
    Berti R; Williams AJ; Velarde LC; Moffett JR; Elliott PJ; Adams J; Yao C; Dave JR; Tortella FC
    Neurotox Res; 2003; 5(7):505-14. PubMed ID: 14715434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production.
    Liou KT; Shen YC; Chen CF; Tsao CM; Tsai SK
    Brain Res; 2003 Dec; 992(2):159-66. PubMed ID: 14625055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats.
    Toung TJ; Bhardwaj A; Dawson VL; Dawson TM; Traystman RJ; Hurn PD
    Stroke; 1999 Jun; 30(6):1279-85. PubMed ID: 10356112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
    Pei Z; Pang SF; Cheung RT
    Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
    Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N
    Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
    Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
    J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
    Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
    Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of Gualou Guizhi decoction in transient focal cerebral ischemic brains. [Corrected].
    Hu HX; Lin RH; Zhu XQ; Li ZF; Chen LD
    Mol Med Rep; 2015 Jul; 12(1):1321-7. PubMed ID: 25815521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.